Company research
Skye Bioscience, Inc.
CIK 1516551Updated Sep 24, 2026
SecuritySKYE · NASDAQ · equity
Name history
Emerald Bioscience, Inc. · through Jan 7, 2021Nemus Bioscience, Inc. · through Mar 14, 2019LOAD GUARD LOGISTICS, INC. · through Oct 30, 2014LOAD GUARD TRANSPORTATION, INC. · through Nov 7, 2012
SKYE price & chart
Loading TradingView…
NASDAQ:SKYE on TradingView ↗In the news
Kuehn Law Encourages Investors of Skye Bioscience, Inc. to Contact Law Firm ↗
Skye Bioscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SKYE News provided by DJS Law Group LLP Jan 19, 2026, 02:13 ET Share this article Share to X Share this article Share to X LOS ANGELES , Jan. 19, 2026 /PRNewswire/ -- The DJS Law Group remi ↗
SKYE Investors Have Opportunity to Lead Skye Bioscience, Inc. Securities Fraud Lawsuit with the Schall Law Firm News provided by The Schall Law Firm Jan 19, 2026, 02:04 ET Share this article Share to X Share this article Share to X LOS ANGELES , Jan. 19, 2026 /PRNewswire/ -- The Schall Law Firm , a ↗
Recent filings
DEFA14A filing
Termination of a Material Definitive Agreement · Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · Other Events
Items 1.02, 5.02, 8.01
DEFA14A filing
Entry into a Material Definitive Agreement · Unregistered Sales of Equity Securities
Items 1.01, 3.02, 9.01
DEFA14A filing
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 28,313,633Source | 72,763,773Source | 11,940,411Source | 9,111,072Source |
| Property, Plant and Equipment, NetUSD | 898,930Source | 1,432,752Source | 43,276Source | 87,854Source |
| Current assets: | ||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 5,882,498Source | 68,415,741Source | — | — |
| Assets, CurrentUSD | 27,094,147Source | 70,827,247Source | 11,650,843Source | 8,943,718Source |
| Operating Lease, Right-of-Use AssetUSD | 266,646Source | 449,864Source | 237,983Source | 71,191Source |
| Other Assets, NoncurrentUSD | 53,910Source | 53,910Source | 8,309Source | 8,309Source |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 8,289,458Source | 4,612,049Source | 14,072,229Source | 12,119,126Source |
| Stockholders’ equity: | ||||
| Preferred Stock, Value, IssuedUSD | 0Source | 0Source | 0Source | 0Source |
| Common Stock, Value, IssuedUSD | 33,379Source | 30,975Source | 12,349Source | 913,528Source |
| Retained Earnings (Accumulated Deficit)USD | -186,874,486Source | -130,949,672Source | -104,382,549Source | -66,737,765Source |
| Stockholders' Equity Attributable to ParentUSD | 20,024,175Source | 68,151,724Source | -2,131,818Source | -3,008,054Source |
| Additional Paid in Capital, Common StockUSD | 206,865,282Source | 199,070,421Source | 102,238,382Source | 62,816,183Source |
| Liabilities and EquityUSD | 28,313,633Source | 72,763,773Source | 11,940,411Source | 9,111,072Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 8,205,459Source | 4,338,887Source | 13,900,999Source | 12,119,126Source |
| Operating Lease, Liability, CurrentUSD | 189,647Source | 182,428Source | 72,038Source | 78,700Source |
| Accounts Payable, CurrentUSD | 2,033,431Source | — | — | 1,669,997Source |
| Operating Lease, Liability, NoncurrentUSD | 83,999Source | 273,162Source | 171,230Source | 0Source |
| Additional Financial Items | ||||
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 25,737,221Source | — | — | — |
| Short-term InvestmentsUSD | 19,854,723Source | — | — | — |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 723,352Source | 298,640Source | — | — |
| Share-based Payment Arrangement, Noncash ExpenseUSD | 7,767,694Source | 8,317,480Source | 987,510Source | 629,032Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -43,062,529Source | -25,237,480Source | -13,952,178Source | -12,744,072Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -19,500,285Source | -245,615Source | 6,596,456Source | 5,214,395Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 6,312Source | 1,604,027Source | 12,550Source | 28,060Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 29,571Source | 83,562,181Source | 16,443,270Source | -208,794Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | -62,533,243Source | 58,079,086Source | 9,087,548Source | -7,738,471Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 5,882,498Source | 68,415,741Source | 10,336,655Source | 1,249,107Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 0Source | 433,336Source | 198,352Source | 333,547Source |
| Additional Financial Items | ||||
| Share-based Payment Arrangement, ExpenseUSD | 7,767,694Source | 8,317,480Source | 987,510Source | 608,199Source |
| Amortization of Debt Issuance CostsUSD | — | 16,456Source | 9,063Source | 1,359Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | 0Source | 599,006Source | 329,890Source | 489,595Source |
| Cash, Cash Equivalents, and Short-term InvestmentsUSD | 25,737,221Source | — | — | — |
| DepreciationUSD | 540,135Source | 203,757Source | 124,251Source | 114,998Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | 0Source | 45,350Source | -3,352Source |
| Gain (Loss) on Disposition of BusinessUSD | 360,750Source | 1,358,412Source | -307,086Source | — |
| Gain (Loss) on Disposition of Other AssetsUSD | 0Source | -10,794Source | 4,080Source | — |
| Gain (Loss) Related to Litigation SettlementUSD | — | 4,234,717Source | 151,842Source | -6,205,310Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | -307,086Source | 0Source |
| General and Administrative ExpenseUSD | 15,801,686Source | 17,725,741Source | 7,852,340Source | 6,094,617Source |
| Income Tax Expense (Benefit)USD | 5,400Source | 10,071Source | 3,600Source | 6,741Source |
| Induced Conversion of Convertible Debt ExpenseUSD | — | 0Source | 1,383,285Source | — |
| InterestExpenseNonoperatingUSD | 0Source | 749,308Source | — | — |
| Investment Income, InterestUSD | 1,883,903Source | 3,028,762Source | 99,974Source | 19,011Source |
| Net Income (Loss) Attributable to ParentUSD | -55,924,814Source | -26,567,123Source | -37,644,784Source | -19,481,602Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -55,924,814Source | -26,567,123Source | -37,644,784Source | -19,481,602Source |
| Nonoperating Income (Expense)USD | 2,244,151Source | 3,635,666Source | -2,906,011Source | -1,163,129Source |
| Operating ExpensesUSD | 58,163,565Source | 30,192,718Source | 34,735,173Source | 18,311,732Source |
| Other Nonoperating Income (Expense)USD | -502Source | -2,200Source | — | — |
| Payments of Financing CostsUSD | — | 0Source | 6,026Source | — |
| Proceeds from Issuance of Common StockUSD | — | 0Source | 4,973,684Source | 0Source |
| Proceeds from Stock Options ExercisedUSD | 0Source | 5,618Source | — | 0Source |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Operating Income (Loss)USD | -58,163,565Source | -30,192,718Source | -34,735,173Source | -18,311,732Source |
| Other Nonoperating Income (Expense)USD | -502Source | -2,200Source | — | — |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -55,919,414Source | -26,557,052Source | -37,641,184Source | -19,474,861Source |
| Income Tax Expense (Benefit)USD | 5,400Source | 10,071Source | 3,600Source | 6,741Source |
| Net Income (Loss) Attributable to ParentUSD | -55,924,814Source | -26,567,123Source | -37,644,784Source | -19,481,602Source |
| Earnings Per Share, BasicUSD per share | -1.41Source | -0.73Source | -5.37Source | -0.04Source |
| Earnings Per Share, DilutedUSD per share | -1.41Source | -0.73Source | -5.37Source | -0.04Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 39,662,664Source | 36,486,519Source | 7,006,038Source | 555,270,089Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 39,662,664Source | 36,486,519Source | 7,006,038Source | 555,270,089Source |
| Interest Expense (non-operating)USD | 0Source | 749,308Source | — | — |
| Additional Financial Items | ||||
| Current Income Tax Expense (Benefit)USD | 5,400Source | 10,071Source | 3,600Source | 6,741Source |
| Foreign Currency Transaction Gain (Loss), before TaxUSD | — | 0Source | 45,350Source | -3,352Source |
| Gain (Loss) Related to Litigation SettlementUSD | — | 4,234,717Source | 151,842Source | -6,205,310Source |
| General and Administrative ExpenseUSD | 15,801,686Source | 17,725,741Source | 7,852,340Source | 6,094,617Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | -56,242,571Source | -27,495,672Source | -25,799,330Source | -18,801,570Source |
| Interest ExpenseUSD | 0Source | 749,308Source | 906,270Source | 665,133Source |
| Interest Expense, DebtUSD | — | — | — | 0Source |
| Investment Income, InterestUSD | 1,883,903Source | 3,028,762Source | 99,974Source | 19,011Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | -55,924,814Source | -26,567,123Source | -37,644,784Source | -19,481,602Source |
| Nonoperating Income (Expense)USD | 2,244,151Source | 3,635,666Source | -2,906,011Source | -1,163,129Source |
| Operating ExpensesUSD | 58,163,565Source | 30,192,718Source | 34,735,173Source | 18,311,732Source |
| Research and Development ExpenseUSD | — | — | — | 6,011,805Source |